SurvivorNet on MSN
Enhertu significantly cuts recurrence rates for women with high-risk HER2-positive breast cancer — the practice-changing DESTINY-Breast05 trial
DESTINY-Breast05 is a large phase 3 trial in women with HER2-positive early-stage breast cancer who had chemotherapy and ...
A retrospective analysis shows that low postoperative thyroglobulin levels are associated with a low risk for recurrence in ...
A new risk score can help predict which pancreatic cancer survivors are more likely to suffer a recurrence of their cancer, ...
What Is Recurrent Endometrial Cancer? Endometrial cancer is a type of cancer that starts in the lining of the uterus, called the endometrium. It's the most common form of gynecologic cancer in the ...
One large study found that more advanced cases of colorectal cancer had a higher likelihood of returning. For example, if participants had stage 3 colon cancer, almost 25 percent experienced a ...
Radiation has been a staple of breast cancer treatment for decades, but a new study is casting doubt on whether it is ...
A Purdue University mechanical engineer and his international collaborators have developed a patent-pending method and algorithm to predict the recurrence of prostate cancer in patients treated by ...
At the San Antonio Breast Cancer Symposium, investigators reported phase III results showing that the oral selective estrogen ...
For many cancer survivors, the end of treatment does not mean the end of fear. The final chemotherapy session or last ...
A joint research team of the Korea Advanced Institute of Science and Technology (KAIST) and domestic biotechnology firm ...
Cancer is a chronic condition that can reoccur after effective treatment. Fear of cancer recurrence (FCR) is common and can negatively affect a person’s daily life. Although fear of the unknown is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results